Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
medicare
12
×
national blog main
boston blog main
national top stories
san francisco blog main
san francisco top stories
biotech
boston top stories
national
san diego blog main
san diego top stories
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
president trump
biogen
drug prices
novartis
pfizer
startups
abbvie
alzheimer's disease
bristol-myers squibb
cancer
cancer immunotherapy
eli lilly
What
drug
12
×
prices
bio
plan
roundup
lower
patients
prescription
price
trump
administration
alzheimer’s
awaited
blueprint
companies
details
house
long
new
pharma
pharmaceutical
today
acquisitions
adding
advantages
afternoon
albert
anathema
angry
announced
annual
anti
anticipated
approval
assessed
attention
away
bar
benefited
bets
Language
unset
unknown
Current search:
medicare
×
drug
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details